Clinical Trial Update: Phase IV Observational Study in Chronic Lymphocytic Leukemia

View source ↗

Summary

GlaxoSmithKline conducted a Phase IV observational study in chronic lymphocytic leukemia. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Status: COMPLETED